Download presentation
Presentation is loading. Please wait.
1
Updates in Progressive MS
2
Therapeutic Milieu for Progressive MS
3
Ocrelizumab
4
Anti-inflammatory Properties of DMTs for PPMS
5
Treating Active SPMS Siponimod
6
Labeling for Novel Agents in Progressive MS
7
A Novel Treatment in Active SPMS Cladribine
8
FDA Is Using Phenotypic Classification for Progressive MS
9
Improved Efficacy in Progressive MS With Next-Generation S1P Inhibitor
10
PPMS vs SSPS What Is the Difference?
11
Can Anti-Inflammatory Intervention Prevent SP Disease?
12
Progressive MS is a Multifactorial Disease
13
Silent Progression
14
Brain Atrophy in PPMS vs SPMS Treated With Ibudilast
15
Biomarkers for SPMS CNS Inflammation
16
Biomarkers for SPMS CNS Inflammation: Results
17
Biomarkers for SPMS Cervical Cord Atrophy
18
Biomarkers for SPMS Cervical Cord Atrophy (cont)
19
Biomarkers for SPMS Atrophied T2-LV
20
Biomarkers for SPMS NfL
21
Concluding Remarks
22
Abbreviations
23
Abbreviations (cont)
24
Abbreviations (cont)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.